Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

All Drugs Associated with Bladder transitional cell carcinoma (Page 2)

91 drugs have been associated with Bladder transitional cell carcinoma in FAERS reports.

Drug Reports Deaths Hosp. Life-Threat.
LEUPROLIDE 17 1 4 0
METFORMIN\PIOGLITAZONE 17 2 2 0
SIROLIMUS 17 0 0 0
CEFPODOXIME 15 0 15 0
DIMETHYL 13 1 6 0
AZATHIOPRINE 12 3 6 2
TRIMETHOPRIM 12 0 12 0
UNSPECIFIED INGREDIENT 12 2 9 0
LEFLUNOMIDE 11 0 6 0
CLINDAMYCIN\CLOTRIMAZOLE 10 0 10 0
DAPAGLIFLOZIN 9 0 6 1
VEDOLIZUMAB 9 1 4 0
IMATINIB 8 0 2 0
PEMBROLIZUMAB 8 2 3 1
SULFAMETHOXAZOLE 8 0 8 0
BARICITINIB 7 0 0 0
BORTEZOMIB 7 0 2 0
CLIOQUINOL\FLUMETHASONE PIVALATE 7 0 7 0
EVEROLIMUS 7 0 0 0
TRIMIPRAMINE 7 0 7 0
VINCRISTINE 7 0 2 0
ABATACEPT 6 0 3 0
CYCLOSPORINE 6 1 0 0
DOXORUBICIN 6 1 0 0
ESCITALOPRAM OXALATE 6 0 0 0
ETOPOSIDE 6 1 6 0
MELPHALAN 6 2 4 0
RUXOLITINIB 6 1 5 1
SECUKINUMAB 6 0 1 0
TOFACITINIB 6 0 6 0
ASPIRIN 5 0 1 4
ATORVASTATIN 5 0 0 4
CISPLATIN 5 2 3 0
EMPAGLIFLOZIN 5 0 1 0
ENZALUTAMIDE 5 0 0 0
GEMCITABINE 5 2 0 0
GLATIRAMER 5 0 5 0
METHYLPREDNISOLONE 5 3 3 2
NATALIZUMAB 5 0 3 1
OCRELIZUMAB 5 0 4 0
PACLITAXEL 5 3 1 0
« 1 2